﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Hamadan University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Research in Health Sciences</JournalTitle>
      <Issn>2228-7795</Issn>
      <Volume>7</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2007</Year>
        <Month>12</Month>
        <DAY>28</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Some Biomarkers in Acute Myocardial Infarction</ArticleTitle>
    <FirstPage>11</FirstPage>
    <LastPage>19</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>AM</FirstName>
        <LastName>Amiri Majd</LastName>
      </Author>
      <Author>
        <FirstName>M</FirstName>
        <LastName>Rezaei</LastName>
      </Author>
      <Author>
        <FirstName>MT</FirstName>
        <LastName>Goodarzi</LastName>
      </Author>
      <Author>
        <FirstName>S</FirstName>
        <LastName>Homayoonfar</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2011</Year>
        <Month>07</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <Abstract>Background: Several changes in serum biochemical factors occur in acute myocardial infarction (AMI). Recently alterations in serum levels of homocysteine (Hcy), sialic acid (SA) and high sensitive C-reactive protein (HS-CRP) has been attended as risk factors and index for prediction. This study was aimed to show the alterations in these factors and their relationships in AMI.Methods: Thirty four patients with AMI were enrolled in this case-control study. Also 51 apparently healthy individuals were selected as control group. Serum was prepared from all subjects in fasting state. Hcy and HS-CRP were measured using ELISA and SA was determined by Erlich method. Results: Serum levels of Hcy, SA and HS-CRP in AMI patients were 14.35Ã‚Â±2.55ÃŽÂ¼mol/l, 73.54Ã‚Â±2.82 mg/dl, and 17.32Ã‚Â±3.45 mg/l, respectively and in the control group they were 8.31Ã‚Â±2.66 ÃŽÂ¼mol/l, 59.82Ã‚Â±2.70 mg/dl and 2.77Ã‚Â±1.98 mg/l, respectively. Statistical analysis of data showed that serum level of Hcy, SA, and HS-CRP in the patients with AMI was significantly higher than those of control (P &lt; 0.001). Also significant correlation was observed between Hcy-HS-CRP (r= 0.63), SA- Hcy (r= 0.73), and SA - CRP (r= 0.75) (P &lt; 0.05 for all items).Conclusion: Our findings showed increased level of HS-CRP, SA, and Hcy in AMI patients. Also obtained data indicated a direct and significant correlation between HS-CRP as an inflammation index and Hcy and SA. Hence these two factors can be used as biomarkers in this disease.</Abstract>
  </Article>
</ArticleSet>